SCHEMBL6787155

SCHEMBL6787155

Cc1cc2[nH]c3cnn(C)c3c(=O)c2cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.38
IDO1 P14902 1/20 0.32
PIP4K2A P48426 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
CASP1 P29466 1/20 0.31
HTT P42858 1/20 0.31
CASP7 P55210 1/20 0.31
ATM Q13315 1/20 0.31
HSD17B10 Q99714 1/20 0.31
IMPDH2 P12268 1/20 0.31
PRMT5 O14744 1/20 0.30
WDR77 Q9BQA1 1/20 0.30
CTSV O60911 1/20 0.30
CTSL P07711 1/20 0.30
MPO P05164 1/20 0.30
XDH P47989 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6785897 0.94 DAO (0.35) DAOPIP4K2AKDM4EALDH1A1GLA
SCHEMBL6787118 0.90 MPO (0.38) DAOKDM4EALDH1A1GLAGAA
SCHEMBL6792539 0.88 GRIN2D (0.36) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL6786716 0.81 AURKA (0.32)
SCHEMBL6786900 0.79 KDM4E (0.51) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL6783202 0.79 FEN1 (0.42) DAOKDM4EALDH1A1GLAGAA
SCHEMBL6781520 0.77 MEN1 (0.53) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL6785080 0.77 ABCB1 (0.37) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL6791986 0.77 ABCB1 (0.37) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL6787376 0.74 DAO (0.38) DAOKDM4EALDH1A1GLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG DAO 1867/4885IDO1 3237/4885PIP4K2A 506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.